Your doctor is the best source for information about your pulmonary arterial hypertension (PAH) (WHO Group 1). Below you’ll find a list of questions you can ask your doctor to help you better understand your treatment.
Adempas is approved to treat adults with PAH (WHO Group 1). The Adempas clinical studies included mostly patients with WHO functional class II-III symptoms. It is not known if Adempas is safe and effective in children.
WHO=World Health Organization